CHILE - International Agency for Research on Cancer · CHILE . This country profile for the Cancer in Central and South America project provides, for each participating cancer registry

Cancer in Central and South America

CHILE

This country profile for the Cancer in Central and South America project provides, for each participating cancer registry tables and graphics showing numbers of cases and rates by year, sex and age group for major sites of cancer together with a population pyramid. A country summary is also provided based on aggregated registry data and national mortality data from the WHO mortality database: (http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html) Citation of any of these data should be in the following format: “Sierra MS, Abriata MG, Barrios E, Bravo LE, Cueva P, Fernandez L, Pineros M, Rebelo M, de Vries E, Forman D. Editors on behalf of the Cancer in Central and South America Working Group (2016). Cancer in Central and South America. Lyon: International Agency for Research on Cancer. Available from: http://www-dep.iarc.fr/CSU_resources.htm accessed [date].”

http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html

http://www-dep.iarc.fr/CSU_resources.htm

Registry Summary Tables and Figures

CHILE, ANTOFAGASTA (2003-2007)

Registry Director*: Mr Juan Carlos Galaz Alamos

Registry Staff*: Jessica Moya Cortés

*Director and staff as notified at time of call for data in 2013. Current contact information for cancer registries in the

region can be found at: http://www.iacr.com.fr/index.php?option=com_comprofiler&task=usersList&listid=5.

CSA - 2

http://www.iacr.com.fr/index.php?option=com_comprofiler&task=usersList&listid=5

CHILE, ANTOFAGASTA (2003-2007)Number of Cases in Major Diagnosis Groups

per Calendar Year

YEAR

SITE 2003n (%)

2004n (%)

2005n (%)

2006n (%)

2007n (%)

TOTALn (%)

MALESLip, oral cavity, and pharynx (C00-C14) 5 (0.9) 10 (1.5) 7 (1.3) 11 (1.6) 9 (1.3) 42 (1.3)Digestive organs (C15-C26) 101 (18.7) 143 (21.9) 113 (20.6) 151 (21.8) 134 (19.8) 642 (20.6)Respiratory organs (C30-C39) 119 (22.0) 132 (20.2) 136 (24.8) 152 (21.9) 152 (22.4) 691 (22.2)Bone, cartilage, and skin (C40-C44) 99 (18.3) 131 (20.1) 102 (18.6) 136 (19.6) 137 (20.2) 605 (19.4)Breast (C50) 0 (0.0) 1 (0.2) 1 (0.2) 0 (0.0) 0 (0.0) 2 (0.1)Male genitalia (C60-C63) 109 (20.2) 105 (16.1) 87 (15.8) 106 (15.3) 103 (15.2) 510 (16.4)Urinary organs (C64-C68) 68 (12.6) 71 (10.9) 51 (9.3) 76 (11.0) 76 (11.2) 342 (11.0)Eye, brain, and thyroid (C69-C75) 4 (0.7) 13 (2.0) 9 (1.6) 11 (1.6) 13 (1.9) 50 (1.6)Hematopoietic (C81-C96) 26 (4.8) 35 (5.4) 31 (5.6) 33 (4.8) 28 (4.1) 153 (4.9)Other and unspecified 9 (1.7) 11 (1.7) 12 (2.2) 17 (2.5) 26 (3.8) 75 (2.4)All sites 540 (100.0) 652 (100.0) 549 (100.0) 693 (100.0) 678 (100.0) 3112 (100.0)

FEMALESLip, oral cavity, and pharynx (C00-C14) 4 (0.9) 4 (0.8) 5 (0.9) 7 (1.1) 10 (1.6) 30 (1.1)Digestive organs (C15-C26) 102 (23.0) 109 (21.0) 116 (20.2) 88 (14.1) 123 (19.2) 538 (19.2)Respiratory organs (C30-C39) 48 (10.8) 61 (11.8) 50 (8.7) 66 (10.6) 59 (9.2) 284 (10.1)Bone, cartilage, and skin (C40-C44) 86 (19.4) 112 (21.6) 112 (19.5) 131 (21.0) 136 (21.3) 577 (20.6)Breast (C50) 74 (16.7) 78 (15.1) 101 (17.6) 106 (17.0) 111 (17.4) 470 (16.8)Female genitalia (C51-C58) 50 (11.3) 61 (11.8) 59 (10.3) 76 (12.2) 68 (10.6) 314 (11.2)Urinary organs (C64-C68) 30 (6.8) 40 (7.7) 40 (7.0) 51 (8.2) 50 (7.8) 211 (7.5)Eye, brain, and thyroid (C69-C75) 15 (3.4) 19 (3.7) 37 (6.4) 48 (7.7) 34 (5.3) 153 (5.5)Hematopoietic (C81-C96) 24 (5.4) 26 (5.0) 39 (6.8) 35 (5.6) 34 (5.3) 158 (5.6)Other and unspecified 10 (2.3) 8 (1.5) 15 (2.6) 17 (2.7) 14 (2.2) 64 (2.3)All sites 443 (100.0) 518 (100.0) 574 (100.0) 625 (100.0) 639 (100.0) 2799 (100.0)

BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 9 (0.9) 14 (1.2) 12 (1.1) 18 (1.4) 19 (1.4) 72 (1.2)Digestive organs (C15-C26) 203 (20.7) 252 (21.5) 229 (20.4) 239 (18.1) 257 (19.5) 1180 (20.0)Respiratory organs (C30-C39) 167 (17.0) 193 (16.5) 186 (16.6) 218 (16.5) 211 (16.0) 975 (16.5)Bone, cartilage, and skin (C40-C44) 185 (18.8) 243 (20.8) 214 (19.1) 267 (20.3) 273 (20.7) 1182 (20.0)Urinary organs (C64-C68) 98 (10.0) 111 (9.5) 91 (8.1) 127 (9.6) 126 (9.6) 553 (9.4)Eye, brain, and thyroid (C69-C75) 19 (1.9) 32 (2.7) 46 (4.1) 59 (4.5) 47 (3.6) 203 (3.4)Hematopoietic (C81-C96) 50 (5.1) 61 (5.2) 70 (6.2) 68 (5.2) 62 (4.7) 311 (5.3)Other and unspecified 19 (1.9) 19 (1.6) 27 (2.4) 34 (2.6) 40 (3.0) 139 (2.4)All sites 983 (100.0) 1170 (100.0) 1123 (100.0) 1318 (100.0) 1317 (100.0) 5911 (100.0)

1

CSA - 3

CHILE, ANTOFAGASTA (2003-2007)Age Standardized Incidence Rate (World Population) per 100,000

in Major Diagnosis Groups per Calendar Year

YEAR

SITE 2003ASR (%)

2004ASR (%)

2005ASR (%)

2006ASR (%)

2007ASR (%)

TOTALASR (%)

MALESLip, oral cavity, and pharynx (C00-C14) 2.3 (0.9) 4.6 (1.5) 2.6 (1.0) 4.8 (1.6) 4.0 (1.4) 3.7 (1.3)Digestive organs (C15-C26) 49.7 (19.3) 67.7 (22.2) 52.4 (21.3) 68.0 (22.6) 56.9 (20.2) 59.0 (21.2)Respiratory organs (C30-C39) 57.7 (22.4) 64.4 (21.1) 62.1 (25.2) 68.5 (22.7) 65.5 (23.2) 63.8 (22.9)Bone, cartilage, and skin (C40-C44) 44.3 (17.2) 58.9 (19.3) 43.5 (17.7) 57.4 (19.1) 55.9 (19.8) 52.2 (18.7)Breast (C50) 0 (0.0) 0.6 (0.2) 0.5 (0.2) 0 (0.0) 0 (0.0) 0.2 (0.1)Male genitalia (C60-C63) 54.0 (20.9) 49.8 (16.3) 40.5 (16.5) 45.9 (15.2) 42.3 (15.0) 46.4 (16.6)Urinary organs (C64-C68) 31.8 (12.3) 33.9 (11.1) 22.4 (9.1) 32.9 (10.9) 31.7 (11.2) 30.6 (11.0)Eye, brain, and thyroid (C69-C75) 1.6 (0.6) 5.7 (1.9) 3.7 (1.5) 3.9 (1.3) 4.6 (1.6) 3.9 (1.4)Hematopoietic (C81-C96) 11.7 (4.5) 15.0 (4.9) 13.3 (5.4) 13.1 (4.3) 11.2 (4.0) 12.8 (4.6)Other and unspecified 4.7 (1.8) 5.1 (1.7) 5.2 (2.1) 6.8 (2.2) 10.1 (3.6) 6.5 (2.3)All sites 258.0 (100.0) 305.7 (100.0) 246.0 (100.0) 301.2 (100.0) 282.2 (100.0) 278.9 (100.0)

FEMALESLip, oral cavity, and pharynx (C00-C14) 1.8 (1.0) 1.5 (0.7) 1.8 (0.8) 2.6 (1.1) 3.7 (1.6) 2.3 (1.1)Digestive organs (C15-C26) 43.4 (23.7) 42.1 (20.7) 44.1 (20.0) 31.8 (13.7) 44.2 (19.4) 41.1 (19.2)Respiratory organs (C30-C39) 20.1 (11.0) 25.1 (12.3) 19.2 (8.7) 26.2 (11.3) 21.2 (9.3) 22.4 (10.5)Bone, cartilage, and skin (C40-C44) 34.0 (18.6) 43.3 (21.3) 42.0 (19.0) 48.8 (21.0) 48.1 (21.1) 43.5 (20.3)Breast (C50) 30.5 (16.7) 30.5 (15.0) 39.7 (18.0) 39.6 (17.0) 39.3 (17.2) 36.0 (16.8)Female genitalia (C51-C58) 20.3 (11.1) 23.3 (11.4) 22.2 (10.0) 28.4 (12.2) 23.5 (10.3) 23.6 (11.0)Urinary organs (C64-C68) 13.4 (7.3) 16.1 (7.9) 16.2 (7.3) 18.8 (8.1) 18.2 (8.0) 16.7 (7.8)Eye, brain, and thyroid (C69-C75) 5.6 (3.1) 7.6 (3.7) 14.9 (6.7) 17.2 (7.4) 11.9 (5.2) 11.5 (5.4)Hematopoietic (C81-C96) 10.1 (5.5) 10.9 (5.4) 14.7 (6.6) 12.7 (5.5) 12.5 (5.5) 12.2 (5.7)Other and unspecified 4.0 (2.2) 3.2 (1.6) 6.2 (2.8) 6.4 (2.7) 5.4 (2.4) 5.0 (2.4)All sites 183.1 (100.0) 203.6 (100.0) 221.1 (100.0) 232.5 (100.0) 228.2 (100.0) 214.4 (100.0)

BOTH SEXESLip, oral cavity, and pharynx (C00-C14) 2.0 (0.9) 3.0 (1.2) 2.2 (1.0) 3.6 (1.4) 3.8 (1.5) 3.0 (1.2)Digestive organs (C15-C26) 45.9 (21.4) 53.8 (21.7) 47.8 (20.8) 48.3 (18.6) 49.9 (20.0) 49.1 (20.4)Respiratory organs (C30-C39) 37.0 (17.3) 43.6 (17.6) 39.4 (17.2) 45.1 (17.4) 42.3 (17.0) 41.6 (17.3)Bone, cartilage, and skin (C40-C44) 39.4 (18.4) 50.1 (20.2) 42.9 (18.7) 52.4 (20.2) 51.0 (20.5) 47.3 (19.7)Urinary organs (C64-C68) 22.0 (10.3) 24.3 (9.8) 19.2 (8.3) 25.4 (9.8) 23.8 (9.6) 23.0 (9.6)Eye, brain, and thyroid (C69-C75) 3.5 (1.6) 6.5 (2.6) 9.1 (4.0) 10.4 (4.0) 8.1 (3.3) 7.6 (3.1)Hematopoietic (C81-C96) 10.8 (5.0) 13.0 (5.2) 14.2 (6.2) 12.6 (4.9) 11.8 (4.7) 12.5 (5.2)Other and unspecified 4.2 (2.0) 4.0 (1.6) 5.6 (2.4) 6.6 (2.5) 7.7 (3.1) 5.7 (2.4)All sites 214.2 (100.0) 248.3 (100.0) 229.7 (100.0) 259.1 (100.0) 249.0 (100.0) 240.6 (100.0)

1

CSA - 4

CHILE,

ANT O

FAGA

STA(2003-2007)

Incid

ence

per1

00,00

0byA

geGr

oup(years)

Males

SITE

ALL

CASE

SUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

R(W

)CU

M.RA

TE(0-74)†

MV (%)

DCO

(%)

Rank‡

ICD1

0

Lip,o

ralcavity,a

ndph

arynx(

C00-14

)42

00.8

..

..

..

0.91.8

6.26.6

5.412

.923

.331

.932

.83.0

3.70.4

581

015

C00-14

Oesoph

agus

(C15

)54

0.

..

..

..

..

4.1.

5.47.7

46.6

74.5

84.2

3.85.3

0.69

6724

8C1

5Stom

ach(

C16)

258

0.

..

.0.8

0.91.7

1.710

.015

.630

.244

.980

.013

9.726

6.028

5.518

.323

.62.9

676

153

C16

Colon

(C18

)99

0.

..

..

0.9.

0.92.7

7.314

.414

.423

.246

.685

.114

5.17.0

8.90.9

879

17C1

8Re

ctum(C19

-20)

530

..

..

.0.9

0.80.9

.4.1

3.918

.012

.934

.916

.074

.93.8

4.70.4

677

17C1

9-20

Color

ectal

(C18

-20)

152

0.

..

..

1.80.8

1.72.7

11.4

18.4

32.4

36.1

81.5

101.1

220.0

10.8

13.7

1.44

7817

5C1

8-20

Anus

(C21

)4

0.

..

..

..

..

..

1.8.

.5.3

9.40.3

0.40.0

410

00

24C2

1Co

lon,rectum

anda

nus(

C18-21

)15

60

..

..

.1.8

0.81.7

2.711.4

18.4

34.1

36.1

81.5

106.4

229.3

11.1

14.0

1.48

7917

C18-21

Liver

(C22

)50

00.8

.0.8

..

0.90.8

0.92.7

1.05.3

7.212

.915

.542

.674

.93.6

4.40.4

644

3613

C22

Gallblad

der(C2

3-24

)56

0.

..

..

0.9.

.0.9

2.15.3

5.423

.223

.337

.210

7.64.0

5.30.4

946

419

C23-24

Pancreas

(C25

)59

0.

..

..

..

.0.9

5.27.9

12.6

23.2

58.2

58.5

23.4

4.25.6

0.83

2941

7C2

5No

se,sinu

ses(

C30-31

)14

0.

..

..

.0.8

0.90.9

.1.3

3.610

.33.9

5.39.4

1.01.2

0.14

7914

22C3

0-31

Laryn

x(C3

2)38

0.

..

..

.0.8

0.90.9

3.15.3

9.015

.519

.421

.337

.42.7

3.30.3

874

1316

C32

Lung

,trache

aand

bron

chus

(C33

-34)

597

0.

..

..

0.91.7

0.911.8

22.8

61.7

163.6

271.0

388.1

505.5

561.6

42.4

55.7

7.14

5626

1C3

3-34

Melan

omao

fskin

(C43

)27

0.

..

1.6.

..

3.40.9

4.13.9

14.4

2.63.9

10.6

4.71.9

2.00.2

310

00

18C4

3Me

sothe

lioma

(C45

)5

0.

..

..

.0.8

0.90.9

..

..

..

9.40.4

0.30.0

110

00

25C4

5Ka

posisarco

ma(C46

)1

0.

..

..

..

0.9.

..

..

..

.0.1

0.10.0

010

00

27C4

6Brea

st(C50

)2

0.

..

..

..

..

..

..

3.9.

4.70.1

0.20.0

210

00

26C5

0Pe

nis(C60

)19

0.

..

..

..

0.9.

2.17.9

3.62.6

3.910

.618

.71.3

1.50.1

684

1120

C60

Prostat

e(C6

1)40

60

..

..

..

.0.9

.10

.413

.166

.562

.026

0.047

3.578

6.228

.839

.54.4

379

152

C61

Testis(C6

2)82

01.7

..

2.45.7

15.8

16.6

8.610

.02.1

2.65.4

2.63.9

.9.4

5.85.1

0.39

917

10C6

2Kidn

ey(C64

)111

00.8

..

..

..

2.61.8

7.310

.521

.651

.654

.395

.812

1.77.9

10.2

1.23

7515

6C6

4Blad

der(C6

7)19

70

..

..

..

.1.7

9.119

.714

.448

.562

.069

.918

0.924

3.414

.017

.62.0

380

134

C67

Brain

,CNS

(C70

-72)

210

4.2.

0.8.

0.8.

..

3.62.1

2.61.8

2.63.9

.14

.01.5

1.70.1

157

3319

C70-72

Thyro

id(C73

)20

0.

..

.0.8

0.91.7

2.60.9

3.13.9

1.82.6

7.810

.6.

1.41.4

0.18

955

21C7

3Ho

dgkin

disea

se(C81

)13

00.8

..

0.8.

0.9.

1.71.8

1.02.6

1.8.

..

9.40.9

0.90.0

610

00

23C8

1No

n-Ho

dgkin

lymph

oma(

C82-85

,C96

)52

02.5

.3.1

0.8.

1.81.7

3.43.6

5.23.9

12.6

7.77.8

26.6

32.8

3.74.1

0.40

100

014

C82-85

,C96

Multip

lemy

eloma

(C88

+C90

)31

0.

..

..

0.9.

0.9.

3.12.6

9.07.7

38.8

21.3

9.42.2

2.90.4

210

00

17C8

8+C9

0Lymp

hoidleu

kaem

ia(C91

)11

01.7

2.50.8

.0.8

0.9.

..

..

.2.6

3.95.3

.0.8

1.00.0

910

00

C91

Myelo

idleu

kaem

ia(C92

-94)

290

1.7.

1.6.

..

0.81.7

0.92.1

1.35.4

7.77.8

10.6

37.4

2.12.5

0.21

100

0C9

2-94

Leukae

miau

nspe

cified

(C95

)17

05.1

0.80.8

0.8.

0.9.

.0.9

1.0.

1.8.

.5.3

14.0

1.21.5

0.09

100

0C9

5Le

ukae

mia(

C91-95

)57

08.5

3.33.1

0.80.8

1.80.8

1.71.8

3.11.3

7.210

.311.6

21.3

51.5

4.04.9

0.39

100

011

C91-95

Othe

rand

unspecifie

d(O&

U)52

0.

0.80.8

..

..

.1.8

4.19.2

19.8

12.9

31.0

42.6

23.4

3.74.5

0.62

6710

12O&

UAllsitesb

utC4

4(AL

LbC4

4)25

560

23.7

4.111.0

14.5

11.4

29.8

30.7

42.2

74.3

149.4

246.9

523.0

764.1

1346

.62112

.328

64.1

181.5

230.4

26.92

7218

ALLb

C44

Allsites(

ALL)

3112

023

.74.1

11.0

15.3

13.8

29.8

34.0

53.3

103.2

190.9

334.9

645.2

980.9

1622

.124

31.5

3392

.922

1.027

8.932

.4777

15AL

L

UNK,

Unknow

n;AS

R(W

),Ag

eStan

dardize

dRate

(WorldPo

pulation

);CU

M.,C

umula

tive;

MV,M

icroscopic

Verification;

DCO,

Death

Certif

icate

Only

†Percent

‡Ran

kbased

onhig

hestAS

Rexclu

ding:

Allsitesb

utC4

4and

Allsites

1

CSA - 5

CHILE,

ANT O

FAGA

STA(2003-2007)

Incid

ence

per1

00,00

0byA

geGr

oup(years)

Female

s

SITE

ALL

CASE

SUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

R(W

)CU

M.RA

TE(0-74)†

MV (%)

DCO

(%)

Rank‡

ICD1

0

Lip,o

ralcavity,a

ndph

arynx(

C00-14

)30

00.9

.0.8

.0.9

..

.1.1

3.63.0

7.87.7

6.917

.122

.72.3

2.30.2

580

318

C00-14

Oesoph

agus

(C15

)38

0.

..

..

.1.0

1.0.

1.21.5

5.95.1

20.6

21.4

51.2

2.92.8

0.29

5821

17C1

5Stom

ach(

C16)

100

0.

..

..

.1.0

3.13.2

12.0

1.517

.725

.737

.764

.210

5.27.7

7.50.8

360

278

C16

Colon

(C18

)12

00

..

.0.9

.1.0

.1.0

7.61.2

7.625

.530

.865

.185

.6113.7

9.39.3

1.13

7718

C18

Rectu

m(C19

-20)

340

..

..

.1.0

1.01.0

.3.6

9.19.8

2.613

.712

.825

.62.6

2.50.2

785

15C1

9-20

Color

ectal

(C18

-20)

154

0.

..

0.9.

2.01.0

2.17.6

4.816

.635

.333

.378

.898

.413

9.311.9

11.9

1.40

7918

3C1

8-20

Anus

(C21

)14

0.

..

..

..

.1.1

1.24.5

2.0.

3.48.6

14.2

1.11.0

0.10

717

24C2

1Co

lon,rectum

anda

nus(

C18-21

)16

80

..

.0.9

.2.0

1.02.1

8.66.0

21.2

37.3

33.3

82.2

107.0

153.5

13.0

12.9

1.51

7817

C18-21

Liver

(C22

)43

00.9

..

..

.1.0

1.0.

.3.0

5.923

.113

.717

.151

.23.3

3.30.3

353

2614

C22

Gallblad

der(C2

3-24

)12

50

..

..

..

..

3.28.4

13.6

11.8

41.0

89.1

72.7

116.5

9.69.9

1.20

5722

5C2

3-24

Pancreas

(C25

)57

0.

..

..

..

1.03.2

2.43.0

11.8

20.5

17.1

25.7

68.2

4.44.2

0.42

3246

13C2

5No

se,sinu

ses(

C30-31

)6

0.

..

..

..

.1.1

1.21.5

.2.6

..

5.70.5

0.40.0

367

1725

C30-31

Laryn

x(C3

2)14

0.

..

..

.1.0

..

1.23.0

3.97.7

.17

.12.8

1.11.1

0.17

797

22C3

2Lu

ng,tr

ache

aand

bron

chus

(C33

-34)

244

0.

..

0.90.9

1.02.9

1.09.7

21.6

21.2

31.4

82.1

133.6

184.0

187.6

18.8

19.4

2.45

5723

2C3

3-34

Melan

omao

fskin

(C43

)27

0.

..

..

.1.0

.3.2

2.49.1

.10

.36.9

12.8

17.1

2.12.1

0.23

100

019

C43

Mesothe

lioma

(C45

)3

0.

..

..

..

.1.1

..

.2.6

3.4.

.0.2

0.30.0

410

00

26C4

5Ka

posisarco

ma(C46

)1

0.

..

.0.9

..

..

..

..

..

.0.1

0.10.0

010

00

27C4

6Brea

st(C50

)47

00

..

..

.2.0

4.821

.840

.098

.492

.2113.7

128.3

116.5

205.4

204.7

36.2

36.0

4.12

915

1C5

0Ce

rvixu

teri (C

53)

161

0.

..

.0.9

4.913

.516

.620

.525

.231

.729

.428

.224

.055

.651

.212

.411.8

1.25

849

4C5

3Co

rpus

uteri (

C54)

390

..

..

..

1.01.0

4.33.6

7.67.8

12.8

13.7

21.4

19.9

3.03.0

0.37

875

16C5

4Ov

ary(C5

6)65

0.

..

..

.2.9

5.24.3

8.410

.615

.718

.037

.717

.125

.65.0

5.10.6

074

1710

C56

Kidn

ey(C64

)69

01.8

..

.0.9

..

.1.1

4.87.6

17.7

30.8

30.8

34.2

51.2

5.35.6

0.65

7117

9C6

4Blad

der(C6

7)12

60

..

..

..

.1.0

6.52.4

9.125

.538

.554

.8111.2

116.5

9.79.8

1.25

7910

6C6

7Brain

,CNS

(C70

-72)

230

1.81.7

1.6.

.1.0

.1.0

2.22.4

1.5.

10.3

3.412

.85.7

1.81.9

0.20

4830

21C7

0-72

Thyro

id(C73

)12

70

..

.1.7

3.84.9

9.611.4

16.2

28.8

28.7

19.6

25.7

24.0

4.325

.69.8

9.40.8

998

27

C73

Hodg

kindis

ease

(C81

)15

0.

.0.8

.1.9

..

1.0.

4.84.5

..

3.48.6

2.81.2

1.10.1

310

00

23C8

1No

n-Ho

dgkin

lymph

oma(

C82-85

,C96

)63

00.9

..

..

2.0.

1.05.4

7.210

.69.8

20.5

13.7

17.1

56.8

4.94.7

0.44

100

011

C82-85

,C96

Multip

lemy

eloma

(C88

+C90

)24

0.

..

..

..

..

2.44.5

.7.7

24.0

8.619

.91.9

2.00.2

410

00

20C8

8+C9

0Lymp

hoidleu

kaem

ia(C91

)18

01.8

2.60.8

0.90.9

..

..

4.83.0

2.02.6

3.4.

2.81.4

1.50.1

110

00

C91

Myelo

idleu

kaem

ia(C92

-94)

250

..

0.80.9

..

1.01.0

3.23.6

1.52.0

7.713

.74.3

14.2

1.91.9

0.20

100

0C9

2-94

Leukae

miau

nspe

cified

(C95

)13

0.

3.4.

..

.1.0

.1.1

.1.5

2.0.

.12

.85.7

1.01.0

0.11

100

0C9

5Le

ukae

mia(

C91-95

)56

01.8

6.01.6

1.70.9

.1.9

1.04.3

8.46.0

5.910

.317

.117

.122

.74.3

4.40.4

210

00

12C9

1-95

Othe

rand

unspecifie

d(O&

U)38

00.9

..

..

..

.1.1

1.24.5

7.818

.020

.612

.834

.12.9

3.10.3

363

1815

O&U

Allsitesb

utC4

4(AL

LbC4

4)22

580

9.77.8

6.56.9

13.1

17.7

45.3

80.1

152.4

277.3

320.3

400.1

649.0

825.5

1086

.715

06.5

174.1

173.5

19.49

7813

ALLb

C44

Allsites(

ALL)

2799

09.7

8.66.5

7.813

.121

.655

.096

.720

1.033

8.539

1.451

3.878

2.410

10.4

1343

.419

10.1

215.9

214.4

24.00

8211

ALL

UNK,

Unknow

n;AS

R(W

),Ag

eStan

dardize

dRate

(WorldPo

pulation

);CU

M.,C

umula

tive;

MV,M

icroscopic

Verification;

DCO,

Death

Certif

icate

Only

†Percent

‡Ran

kbased

onhig

hestAS

Rexclu

ding:

Allsitesb

utC4

4and

Allsites

1

CSA - 6

.11

1010

0

5 15 25 35 45 55 65 75+

Oesophagus (C15)

.11

1010

010

00

5 15 25 35 45 55 65 75+

Stomach (C16)

.11

1010

010

00

5 15 25 35 45 55 65 75+

Colon, rectum & anus (C18−21)

.11

1010

0

5 15 25 35 45 55 65 75+

Liver (C22)

.11

1010

010

00

5 15 25 35 45 55 65 75+

Gallbladder (C23−24)

.11

1010

0

5 15 25 35 45 55 65 75+

Pancreas (C25)

.11

1010

0

5 15 25 35 45 55 65 75+

Larynx (C32)

.11

1010

010

00

5 15 25 35 45 55 65 75+

Lung (C33−34)

.11

1010

0

5 15 25 35 45 55 65 75+

Melanoma of skin (C43)

110

100

1000

5 15 25 35 45 55 65 75+

Breast (C50)

.11

1010

0

5 15 25 35 45 55 65 75+

Cervix uteri (C53)

.11

1010

0

5 15 25 35 45 55 65 75+

Corpus uteri (C54)

Inci

denc

e ra

te (

log

scal

e) p

er 1

00,0

00 p

erso

n−ye

ars

Age in Years

Age−specific incidence rates per 100,000 person−years

CHILE, ANTOFAGASTA (2003−2007)

Males Females CSA - 7

110

100

5 15 25 35 45 55 65 75+

Ovary (C56)

.11

1010

0

5 15 25 35 45 55 65 75+

Penis (C60)

.11

1010

010

00

5 15 25 35 45 55 65 75+

Prostate (C61)

110

100

5 15 25 35 45 55 65 75+

Testis (C62)

.11

1010

010

00

5 15 25 35 45 55 65 75+

Kidney (C64)

110

100

1000

5 15 25 35 45 55 65 75+

Bladder (C67)

.11

1010

0

5 15 25 35 45 55 65 75+

Brain, CNS (C70-72)

.11

1010

0

5 15 25 35 45 55 65 75+

Thyroid (C73)

.11

10

5 15 25 35 45 55 65 75+

Hodgkin disease (C81)

.11

1010

0

5 15 25 35 45 55 65 75+

Non-Hodgkin (C82-85,96)

.11

1010

0

5 15 25 35 45 55 65 75+

Leukaemia (C91-95)

110

100

1000

1000

0

5 15 25 35 45 55 65 75+

All sites but C44

Inci

denc

e ra

te (

log

scal

e) p

er 1

00,0

00 p

erso

n-ye

ars

Age in Years

Age-specific incidence rates per 100,000 person-years

CHILE, ANTOFAGASTA (2003-2007)

Males Females

CSA - 8

0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

23649

24223

25513

24825

24550

22828

24137

23249

22085

19279

15227

11128

7748

5154

3759

4274

22773

23204

24746

23056

21312

20327

20736

19229

18507

16662

13236

10198

7797

5839

4675

7036Males Females

100 10090 9080 8070 7060 6050 5040 4030 3020 2010 100 0

Population in Thousands

Average annual person-yearsCHILE, ANTOFAGASTA (2003-2007)

CSA - 9

Registry Summary Tables and Figures

CHILE, VALDIVIA (1993-2008)

Registry Director*: Mrs. Ana María Jofré Salazar

Registry Staff*: María Enriqueta Bertrán Vives, Katy Elena Heise Mora, Solange Marisel Vargas Gallagher

*Director and staff as notified at time of call for data in 2013. Current contact information for cancer registries in the

region can be found at: http://www.iacr.com.fr/index.php?option=com_comprofiler&task=usersList&listid=5.

CSA - 10

http://www.iacr.com.fr/index.php?option=com_comprofiler&task=usersList&listid=5

CHILE, VALDIVIA (1993-1997)Number of Cases in Major Diagnosis Groups

per Calendar Year

YEAR

SITE 1993n (%)

1994n (%)

1995n (%)

1996n (%)

1997n (%)

TOTALn (%)




1

CSA - 11

CHILE, VALDIVIA (1993-1997)Age Standardized Rate (World Population) per 100,000


YEAR

SITE 1993ASR (%)

1994ASR (%)

1995ASR (%)

1996ASR (%)

1997ASR (%)

TOTALASR (%)

MALESLip, oral cavity, and pharynx (C00-C14) 1.4 (0.8) 4.3 (2.2) 0.5 (0.3) 2.4 (1.2) 4.0 (2.0) 2.6 (1.4)Digestive organs (C15-C26) 65.8 (39.6) 91.2 (46.6) 73.5 (44.9) 90.9 (44.9) 81.5 (40.3) 80.7 (43.3)Respiratory organs (C30-C39) 12.9 (7.8) 10.3 (5.3) 9.7 (5.9) 15.9 (7.8) 16.6 (8.2) 13.1 (7.0)Bone, cartilage, and skin (C40-C44) 12.2 (7.3) 8.7 (4.5) 12.3 (7.5) 10.2 (5.0) 12.5 (6.2) 11.2 (6.0)Breast (C50) 0.5 (0.3) 0.5 (0.3) 0.5 (0.3) 0 (0.0) 0 (0.0) 0.3 (0.2)Male genitalia (C60-C63) 38.7 (23.3) 37.5 (19.2) 28.4 (17.3) 44.9 (22.1) 48.1 (23.8) 39.6 (21.3)Urinary organs (C64-C68) 6.4 (3.9) 8.2 (4.2) 8.3 (5.1) 9.7 (4.8) 9.7 (4.8) 8.5 (4.5)Eye, brain, and thyroid (C69-C75) 3.1 (1.9) 2.6 (1.3) 1.3 (0.8) 3.3 (1.6) 3.9 (1.9) 2.8 (1.5)Hematopoietic (C81-C96) 6.9 (4.2) 9.5 (4.9) 14.6 (8.9) 6.7 (3.3) 12.7 (6.3) 10.1 (5.4)Other and unspecified 18.2 (10.9) 22.8 (11.6) 14.5 (8.9) 18.5 (9.1) 13.3 (6.6) 17.4 (9.4)All sites 166.2 (100.0) 195.7 (100.0) 163.6 (100.0) 202.7 (100.0) 202.2 (100.0) 186.3 (100.0)



1

CSA - 12

CHILE,

V ALD

IVIA

(199

3-19

97)

Incid

ence

per1

00,00

0byA

geGr

oup(yea

rs)

Males

SITE

ALL

CASE

SUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

R(W

)CU

M.RA

TE(0-74)†

MV (%)

DCO

(%)

Rank‡

ICD1

0

Lip,o

ralcavity,a

ndph

arynx(

C00-14

)19

0.

..

..

..

1.6.

2.311.1

.15

.79.7

31.9

10.3

2.22.6

0.36

100

015

C00-14

Oesoph

agus

(C15

)61

0.

..

..

..

..

2.35.6

20.5

39.2

67.8

44.6

108.0

7.07.9

0.90

6910

7C1

5Stom

ach(

C16)

344

0.

.1.2

..

.2.8

11.4

15.5

32.5

77.7

119.6

156.9

310.0

344.4

468.2

39.6

44.3

5.36

6615

1C1

6Co

lon(C18

)39

0.

..

.1.3

..

.1.9

.8.3

3.431

.438

.831

.961

.74.5

5.10.5

964

10C1

8Re

ctum(C19

-20)

330

..

..

..

4.2.

.4.6

2.86.8

19.6

14.5

25.5

66.9

3.84.0

0.39

8212

C19-20

Color

ectal

(C18

-20)

720

..

..

1.3.

4.2.

1.94.6

11.1

10.3

51.0

53.3

57.4

128.6

8.39.1

0.98

7211

6C1

8-20

Anus

(C21

)2

0.

..

..

..

..

..

..

4.8.

5.10.2

0.20.0

250

024

C21

Colon

,rectum

anda

nus(

C18-21

)74

0.

..

.1.3

.4.2

.1.9

4.611.1

10.3

51.0

58.1

57.4

133.8

8.59.3

1.00

7211

C18-21

Liver

(C22

)25

01.1

..

..

.1.4

..

..

3.43.9

33.9

57.4

25.7

2.93.2

0.51

2040

13C2

2Ga

llblad

der(C2

3-24

)82

0.

..

..

..

4.9.

9.313

.927

.339

.263

.076

.513

8.99.4

10.4

1.17

5613

4C2

3-24

Pancreas

(C25

)35

0.

..

..

.1.4

.1.9

4.6.

10.3

23.5

29.1

19.1

66.9

4.04.4

0.45

3414

11C2

5No

se,sinu

ses(

C30-31

)1

0.

..

..

..

.1.9

..

..

..

.0.1

0.10.0

110

00

26C3

0-31

Laryn

x(C3

2)19

0.

..

..

..

..

4.62.8

3.411.8

14.5

38.3

15.4

2.22.5

0.38

685

16C3

2Lu

ng,tr

ache

aand

bron

chus

(C33

-34)

750

..

..

..

1.43.3

.7.0

16.7

20.5

54.9

77.5

70.1

82.3

8.69.9

1.26

4019

5C3

3-34

Melan

omao

fskin

(C43

)10

1.

..

..

1.4.

.1.9

2.32.8

3.4.

9.7.

10.3

1.21.3

0.12

100

019

C43

Mesothe

lioma

(C45

)2

0.

..

..

.1.4

..

..

3.4.

..

.0.2

0.20.0

210

00

25C4

5Ka

posisarco

ma(C46

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

0.

.27

C46

Brea

st(C50

)3

0.

..

..

..

..

..

..

..

15.4

0.30.3

0.00

100

023

C50

Penis

(C60

)8

0.

..

..

..

..

..

.3.9

19.4

6.410

.30.9

1.10.1

510

00

21C6

0Prostat

e(C6

1)26

24

..

..

..

..

..

2.858

.178

.422

7.724

8.768

9.430

.131

.73.1

391

52

C61

Testis(C6

2)62

72.2

..

3.810

.616

.314

.113

.113

.67.0

..

.4.8

6.4.

7.16.6

0.52

980

8C6

2Kidn

ey(C64

)35

3.

2.2.

..

..

.1.9

9.32.8

27.3

19.6

9.738

.315

.44.0

4.70.6

174

010

C64

Blad

der(C6

7)29

1.

..

..

..

..

4.65.6

10.3

11.8

29.1

31.9

36.0

3.33.8

0.48

973

12C6

7Brain

,CNS

(C70

-72)

150

2.21.1

..

..

1.4.

3.94.6

2.86.8

7.8.

6.45.1

1.71.9

0.19

477

17C7

0-72

Thyro

id(C73

)7

0.

.1.2

..

.1.4

3.3.

..

3.4.

4.8.

5.10.8

0.80.0

710

00

22C7

3Ho

dgkin

disea

se(C81

)12

0.

2.21.2

.4.0

.1.4

..

2.32.8

3.4.

..

10.3

1.41.3

0.09

100

018

C81

Non-Ho

dgkin

lymph

oma(

C82-85

,C96

)39

02.2

2.21.2

.2.7

1.4.

1.63.9

7.02.8

10.3

19.6

4.851

.036

.04.5

4.90.5

510

00

9C8

2-85

,C96

Multip

lemy

eloma

(C88

+C90

)10

0.

..

..

..

3.35.8

.2.8

3.4.

9.7.

5.11.2

1.20.1

210

00

20C8

8+C9

0Lymp

hoidleu

kaem

ia(C91

)15

06.6

1.1.

5.1.

..

.1.9

2.3.

..

..

10.3

1.71.8

0.08

100

0C9

1My

eloidleu

kaem

ia(C92

-94)

70

1.11.1

.1.3

..

.1.6

..

..

.9.7

6.4.

0.80.9

0.11

100

0C9

2-94

Leukae

miau

nspe

cified

(C95

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

0.

.C9

5Le

ukae

mia(

C91-95

)22

07.7

2.2.

6.3.

..

1.61.9

2.3.

..

9.76.4

10.3

2.52.7

0.19

100

014

C91-95

Othe

rand

unspecifie

d(O&

U)13

70

4.42.2

.1.3

.2.7

7.04.9

7.813

.911.1

44.4

54.9

106.6

95.7

216.1

15.8

17.1

1.78

4512

3O&

UAllsitesb

utC4

4(AL

LbC4

4)14

1716

19.7

12.0

8.217

.719

.921

.839

.450

.769

.912

3.118

3.339

3.060

0.01109

.212

43.5

2129

.816

3.017

7.919

.7871

10AL

LbC4

4Allsites(

ALL)

1486

1619

.712

.08.2

17.7

19.9

21.8

39.4

54.0

71.8

139.3

188.8

403.3

635.3

1152

.812

69.1

2294

.517

0.918

6.320

.4972

10AL

L

UNK,

Unknow

n;AS

R(W

),Ag

eStan

dardize

dRate

(WorldPo

pulation

);CU

M.,C

umula

tive;

MV,M

icroscopic

Verification;

DCO,

Death

Certif

icate

Only

†Percent

‡Ran

kbased

onhig

hestAS

Rexclu

ding:

Allsitesb

utC4

4and

Allsites

1

CSA - 13

CHILE,

V ALD

IVIA

(199

3-19

97)

Incid

ence

per1

00,00

0byA

geGr

oup(yea

rs)

Female

s

SITE

ALL

CASE

SUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

R(W

)CU

M.RA

TE(0-74)†

MV (%)

DCO

(%)

Rank‡

ICD1

0

Lip,o

ralcavity,a

ndph

arynx(

C00-14

)11

0.

1.1.

1.4.

..

.2.0

..

6.43.6

8.85.5

8.01.3

1.30.1

473

920

C00-14

Oesoph

agus

(C15

)46

0.

..

..

..

..

.11.1

22.5

18.2

35.0

33.3

63.7

5.45.2

0.60

809

8C1

5Stom

ach(

C16)

167

0.

..

..

.4.4

3.310

.121

.38.3

41.8

58.2

127.0

88.7

282.6

19.6

18.0

1.82

5224

5C1

6Co

lon(C18

)42

0.

..

..

..

1.7.

.8.3

9.614

.639

.416

.675

.64.9

4.50.4

567

7C1

8Re

ctum(C19

-20)

250

..

..

..

1.51.7

.9.5

2.86.4

21.8

26.3

5.511.9

2.93.2

0.38

808

C19-20

Color

ectal

(C18

-20)

670

..

..

..

1.53.3

.9.5

11.1

16.1

36.4

65.7

22.2

87.6

7.97.7

0.83

727

6C1

8-20

Anus

(C21

)2

0.

..

..

..

..

..

..

.5.5

4.00.2

0.20.0

310

00

24C2

1Co

lon,rectum

anda

nus(

C18-21

)69

0.

..

..

.1.5

3.3.

9.511.1

16.1

36.4

65.7

27.7

91.6

8.17.9

0.86

727

C18-21

Liver

(C22

)27

01.1

..

..

..

1.72.0

9.52.8

6.410

.9.

22.2

39.8

3.23.0

0.28

3711

15C2

2Ga

llblad

der(C2

3-24

)23

01

..

..

..

1.58.4

8.133

.258

.383

.698

.316

2.117

7.424

6.827

.026

.73.1

760

121

C23-24

Pancreas

(C25

)25

0.

..

..

..

..

4.75.5

.10

.917

.533

.331

.82.9

2.80.3

628

1616

C25

Nose,sinu

ses(

C30-31

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

0.

.26

C30-31

Laryn

x(C3

2)3

0.

..

..

.1.5

..

..

..

4.4.

4.00.4

0.30.0

310

00

23C3

2Lu

ng,tr

ache

aand

bron

chus

(C33

-34)

430

..

..

..

.1.7

4.02.4

5.56.4

32.8

26.3

61.0

35.8

5.15.1

0.70

4716

9C3

3-34

Melan

omao

fskin

(C43

)14

0.

..

..

..

.2.0

7.12.8

9.63.6

8.85.5

8.01.6

1.80.2

010

00

18C4

3Me

sothe

lioma

(C45

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

0.

.26

C45

Kapo

sisarco

ma(C46

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

0.

.26

C46

Brea

st(C50

)18

30

..

..

1.42.9

4.418

.436

.430

.877

.767

.576

.492

.0110.9

95.5

21.5

22.3

2.59

852

3C5

0Ce

rvixu

teri (C

53)

196

0.

..

.1.4

13.0

23.4

38.5

46.5

52.1

52.7

54.7

80.1

74.5

38.8

79.6

23.0

23.4

2.38

933

2C5

3Co

rpus

uteri (

C54)

380

..

..

..

.1.7

..

19.4

16.1

36.4

17.5

33.3

19.9

4.54.8

0.62

870

10C5

4Ov

ary(C5

6)58

0.

..

.1.4

.1.5

5.012

.111.8

16.6

28.9

10.9

35.0

55.5

23.9

6.87.0

0.89

833

7C5

6Kidn

ey(C64

)34

22.3

1.1.

..

..

3.32.0

2.411.1

6.414

.621

.911.1

31.8

4.04.0

0.41

656

11C6

4Blad

der(C6

7)11

01.1

..

..

..

.2.0

.2.8

3.23.6

.16

.611.9

1.31.2

0.15

919

21C6

7Brain

,CNS

(C70

-72)

161

1.13.4

..

.5.8

.1.7

.7.1

2.86.4

..

..

1.92.0

0.15

440

17C7

0-72

Thyro

id(C73

)32

1.

..

1.41.4

8.64.4

5.04.0

2.42.8

3.23.6

21.9

11.1

15.9

3.83.6

0.36

840

13C7

3Ho

dgkin

disea

se(C81

)4

0.

..

.1.4

1.41.5

1.7.

..

..

..

.0.5

0.40.0

310

00

22C8

1No

n-Ho

dgkin

lymph

oma(

C82-85

,C96

)32

01.1

1.1.

.1.4

..

3.32.0

.13

.912

.97.3

13.1

38.8

19.9

3.83.8

0.48

100

012

C82-85

,C96

Multip

lemy

eloma

(C88

+C90

)12

0.

..

..

..

1.7.

.8.3

3.27.3

4.4.

15.9

1.41.4

0.12

100

019

C88+

C90

Lymp

hoidleu

kaem

ia(C91

)10

04.6

2.3.

.1.4

..

..

.2.8

.3.6

4.4.

.1.2

1.30.1

010

00

C91

Myelo

idleu

kaem

ia(C92

-94)

130

1.1.

1.21.4

2.9.

1.51.7

..

..

10.9

8.85.5

.1.5

1.60.1

710

00

C92-94

Leukae

miau

nspe

cified

(C95

)1

01.1

..

..

..

..

..

..

..

.0.1

0.10.0

110

00

C95

Leukae

mia(

C91-95

)24

06.8

2.31.2

1.44.3

.1.5

1.7.

.2.8

.14

.613

.15.5

.2.8

3.00.2

810

00

14C9

1-95

Othe

rand

unspecifie

d(O&

U)15

70

.1.1

2.41.4

1.41.4

4.48.4

10.1

26.1

25.0

57.9

69.1

100.8

133.1

135.3

18.5

18.3

2.21

648

4O&

UAllsitesb

utC4

4(AL

LbC4

4)14

725

17.1

12.6

3.76.8

17.2

34.5

54.0

108.8

145.5

227.4

349.6

459.9

607.8

871.8

920.5

1297

.717

3.117

1.819

.2573

8AL

LbC4

4Allsites(

ALL)

1539

517

.112

.63.7

6.818

.734

.555

.510

8.814

5.523

6.936

0.748

2.461

8.7911.2

964.8

1417

.118

1.017

8.919

.9574

8AL

L

UNK,

Unknow

n;AS

R(W

),Ag

eStan

dardize

dRate

(WorldPo

pulation

);CU

M.,C

umula

tive;

MV,M

icroscopic

Verification;

DCO,

Death

Certif

icate

Only

†Percent

‡Ran

kbased

onhig

hestAS

Rexclu

ding:

Allsitesb

utC4

4and

Allsites

1

CSA - 14

110

100

1000

5 15 25 35 45 55 65 75+

Oesophagus (C15)

110

100

1000

5 15 25 35 45 55 65 75+

Stomach (C16)

110

100

1000

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+

Liver (C22)

110

100

1000

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+

Pancreas (C25)

110

100

5 15 25 35 45 55 65 75+

Larynx (C32)

110

100

5 15 25 35 45 55 65 75+

Lung (C33−34)

110

100

5 15 25 35 45 55 65 75+


110

100

1000

5 15 25 35 45 55 65 75+

Breast (C50)

110

100

5 15 25 35 45 55 65 75+

Cervix uteri (C53)

110

100

5 15 25 35 45 55 65 75+

Corpus uteri (C54)

Inci

denc

e ra

te (

log

scal

e) p

er 1

00,0

00 p

erso

n−ye

ars

Age in Years

Age−specific rates per 100,000 person−years

CHILE, VALDIVIA (1993−1997)


110

100

5 15 25 35 45 55 65 75+

Ovary (C56)

110

100

5 15 25 35 45 55 65 75+

Penis (C60)

110

100

1000

5 15 25 35 45 55 65 75+

Prostate (C61)

110

100

5 15 25 35 45 55 65 75+

Testis (C62)

110

100

5 15 25 35 45 55 65 75+

Kidney (C64)

110

100

5 15 25 35 45 55 65 75+

Bladder (C67)

110

5 15 25 35 45 55 65 75+

Brain, CNS (C70-72)

110

100

5 15 25 35 45 55 65 75+

Thyroid (C73)

110

100

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+

Leukaemia (C91-95)

110

100

1000

1000

0

5 15 25 35 45 55 65 75+

All sites but C44

Inci

denc

e ra

te (

log

scal

e) p

er 1

00,0

00 p

erso

n-ye

ars

Age in Years

Age-specific rates per 100,000 person-years


Males Females

CSA - 16

CHILE, VALDIVIA (2004-2008)Number of Cases in Major Diagnosis Groups

per Calendar Year

YEAR

SITE 2004n (%)

2005n (%)

2006n (%)

2007n (%)

2008n (%)

TOTALn (%)




1

CSA - 17

CHILE, VALDIVIA (2004-2008)Age Standardized Rate (World Population) per 100,000


YEAR

SITE 2004ASR (%)

2005ASR (%)

2006ASR (%)

2007ASR (%)

2008ASR (%)

TOTALASR (%)

MALESLip, oral cavity, and pharynx (C00-C14) 4.4 (1.7) 2.2 (0.9) 3.6 (1.4) 2.5 (1.1) 1.3 (0.6) 2.8 (1.1)Digestive organs (C15-C26) 83.2 (33.3) 70.8 (29.7) 80.8 (31.4) 71.2 (30.8) 79.1 (34.2) 77.1 (31.9)Respiratory organs (C30-C39) 14.6 (5.8) 12.4 (5.2) 15.1 (5.9) 8.8 (3.8) 10.1 (4.4) 12.1 (5.0)Bone, cartilage, and skin (C40-C44) 23.3 (9.3) 21.1 (8.9) 20.7 (8.0) 17.4 (7.5) 23.7 (10.3) 21.2 (8.8)Breast (C50) 0.4 (0.2) 0 (0.0) 0.5 (0.2) 0 (0.0) 0 (0.0) 0.2 (0.1)Male genitalia (C60-C63) 80.3 (32.1) 78.2 (32.8) 79.1 (30.7) 81.6 (35.3) 70.4 (30.4) 77.8 (32.2)Urinary organs (C64-C68) 15.5 (6.2) 14.8 (6.2) 19.1 (7.4) 10.3 (4.4) 14.3 (6.2) 14.7 (6.1)Eye, brain, and thyroid (C69-C75) 2.8 (1.1) 6.8 (2.9) 5.9 (2.3) 9.7 (4.2) 6.7 (2.9) 6.4 (2.6)Hematopoietic (C81-C96) 9.7 (3.9) 19.5 (8.2) 19.3 (7.5) 18.1 (7.8) 17.6 (7.6) 16.9 (7.0)Other and unspecified 16.0 (6.4) 12.2 (5.1) 13.5 (5.2) 11.6 (5.0) 8.0 (3.5) 12.2 (5.1)All sites 250.1 (100.0) 238.1 (100.0) 257.6 (100.0) 231.3 (100.0) 231.2 (100.0) 241.4 (100.0)

FEMALESLip, oral cavity, and pharynx (C00-C14) 0.5 (0.2) 0 (0.0) 1.4 (0.6) 2.4 (1.3) 1.6 (0.9) 1.2 (0.6)Digestive organs (C15-C26) 70.3 (33.1) 61.0 (32.6) 66.5 (30.8) 61.7 (32.8) 59.8 (32.4) 63.7 (32.3)Respiratory organs (C30-C39) 4.0 (1.9) 3.5 (1.9) 8.2 (3.8) 4.7 (2.5) 5.4 (2.9) 5.2 (2.6)Bone, cartilage, and skin (C40-C44) 21.0 (9.9) 20.0 (10.7) 28.3 (13.1) 15.7 (8.3) 23.9 (12.9) 21.8 (11.1)Breast (C50) 34.3 (16.2) 33.0 (17.6) 33.5 (15.5) 36.0 (19.1) 30.4 (16.5) 33.3 (16.9)Female genitalia (C51-C58) 33.1 (15.6) 25.2 (13.5) 29.9 (13.9) 26.7 (14.2) 23.9 (12.9) 27.7 (14.1)Urinary organs (C64-C68) 10.7 (5.1) 9.6 (5.2) 5.8 (2.7) 7.6 (4.1) 7.7 (4.1) 8.2 (4.2)Eye, brain, and thyroid (C69-C75) 9.7 (4.6) 7.1 (3.8) 12.4 (5.8) 10.2 (5.4) 7.5 (4.1) 9.4 (4.8)Hematopoietic (C81-C96) 14.2 (6.7) 13.2 (7.0) 9.6 (4.5) 13.8 (7.3) 14.9 (8.1) 13.1 (6.6)Other and unspecified 14.1 (6.7) 14.5 (7.8) 20.1 (9.3) 8.9 (4.8) 9.5 (5.2) 13.3 (6.8)All sites 212.0 (100.0) 187.1 (100.0) 215.6 (100.0) 187.8 (100.0) 184.5 (100.0) 197.0 (100.0)


1

CSA - 18

110

100

5 15 25 35 45 55 65 75+

Oesophagus (C15)

110

100

1000

5 15 25 35 45 55 65 75+

Stomach (C16)

110

100

1000

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+

Liver (C22)

110

100

1000

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+

Pancreas (C25)

110

100

5 15 25 35 45 55 65 75+

Larynx (C32)

110

100

1000

5 15 25 35 45 55 65 75+

Lung (C33−34)

110

100

5 15 25 35 45 55 65 75+


110

100

1000

5 15 25 35 45 55 65 75+

Breast (C50)

110

100

5 15 25 35 45 55 65 75+

Cervix uteri (C53)

110

100

5 15 25 35 45 55 65 75+

Corpus uteri (C54)

Inci

denc

e ra

te (

log

scal

e) p

er 1

00,0

00 p

erso

n−ye

ars

Age in Years

Age−specific rates per 100,000 person−years



110

100

5 15 25 35 45 55 65 75+

Ovary (C56)

110

100

5 15 25 35 45 55 65 75+

Penis (C60)

110

100

1000

5 15 25 35 45 55 65 75+

Prostate (C61)

110

100

5 15 25 35 45 55 65 75+

Testis (C62)

110

100

1000

5 15 25 35 45 55 65 75+

Kidney (C64)

110

100

5 15 25 35 45 55 65 75+

Bladder (C67)

110

100

5 15 25 35 45 55 65 75+

Brain, CNS (C70-72)

110

100

5 15 25 35 45 55 65 75+

Thyroid (C73)

110

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+


110

100

5 15 25 35 45 55 65 75+

Leukaemia (C91-95)

110

100

1000

1000

0

5 15 25 35 45 55 65 75+

All sites but C44

Inci

denc

e ra

te (

log

scal

e) p

er 1

00,0

00 p

erso

n-ye

ars

Age in Years

Age-specific rates per 100,000 person-years


Males Females

CSA - 20

110

100

1993 1998 2003 2008

Oesophagus (C15)

1010

0

1993 1998 2003 2008

Stomach (C16)

110

100

1993 1998 2003 2008

Colon, rectum and anus (C18−21)

110

1993 1998 2003 2008

Liver (C22)

110

100

1993 1998 2003 2008


110

1993 1998 2003 2008

Pancreas (C25)

.11

10

1993 1998 2003 2008

Larynx (C32)

110

100

1993 1998 2003 2008

Lung (C33−34)

.11

10

1993 1998 2003 2008


1010

0

1993 1998 2003 2008

Breast (C50)

110

100

1993 1998 2003 2008

Cervix uteri (C53)

110

1993 1998 2003 2008

Corpus uteri (C54)Age

sta

ndar

dize

d in

cide

nce

rate

(lo

g sc

ale)

per

100

,000

per

son−

year

s

Calendar Year

Symbols represent observed rates and lines represent the (LOWESS=0.5) smoothed trend

Age standardized incidence rate (World Population) per 100,000 per calendar year



110

100

1993 1998 2003 2008

Ovary (C56)

.11

10

1993 1998 2003 2008

Penis (C60)

1010

0

1993 1998 2003 2008

Prostate (C61)

110

100

1993 1998 2003 2008

Testis (C62)

110

100

1993 1998 2003 2008

Kidney (C64)

.11

10

1993 1998 2003 2008

Bladder (C67)

110

1993 1998 2003 2008

Brain, CNS (C70-72)

.11

10

1993 1998 2003 2008

Thyroid (C73)

.11

10

1993 1998 2003 2008


110

1993 1998 2003 2008

Non-Hodgkin (C82-85,C96)

110

100

1993 1998 2003 2008

Leukaemia (C91-95)

100

1000

1993 1998 2003 2008

All sites but C44

Age

sta

ndar

dize

d in

cide

nce

rate

(lo

g sc

ale)

per

100

,000

per

son-

year

s

Calendar Year


Age standardized incidence rate (World Population) per 100,000 per calendar year


Males Females

CSA - 22

-4.2*

-4.1

-3.0

-2.9

-2.2

-2.0

-1.8

-1.4

-1.4

0.4

1.5

2.9

3.2*

3.9*

4.5*

5.1

7.3*

10.2*

-15 -10 -5 0 5 10 15Estimated Annual Percent Change

Stomach (C16)

Larynx (C32)

Oesophagus (C15)


Gallbladder (C23-24)

Lung (C33-34)

Liver (C22)

Bladder (C67)

Thyroid (C73)


Pancreas (C25)

Leukaemia (C91-95)

Prostate (C61)

Colon, rectum & anus (C18-21)

Testis (C62)

Brain, CNS (C70-72)

Kidney (C64)


* The estimated annual percent change is statistically different from zero (p<=.05)

Estimated Annual Percent Change in Incidenceby Cancer Site in Males, all ages


CSA - 23

-6.2*

-5.8

-4.3

-3.4

-2.6

-2.1

-1.4

-0.9

-0.8

-0.8

-0.5

-0.3

0.9

1.6

1.9

2.5

2.8

3.8

6.2

10.7


Cervix uteri (C53)

Oesophagus (C15)

Ovary (C56)

Stomach (C16)

Bladder (C67)


Lung (C33-34)

Liver (C22)

Pancreas (C25)

Corpus uteri (C54)


Brain, CNS (C70-72)

Larynx (C32)



Breast (C50)

Leukaemia (C91-95)

Kidney (C64)

Thyroid (C73)



Estimated Annual Percent Change in Incidenceby Cancer Site in Females, all ages


CSA - 24

0-40-4

5-95-9

10-1410-14

15-1915-19

20-2420-24

25-2925-29

30-3430-34

35-3935-39

40-4440-44

45-4945-49

50-5450-54

55-5955-59

60-6460-64

65-6965-69

70-7470-74

75+75+

0-40-4

5-95-9

10-1410-14

15-1915-19

20-2420-24

25-2925-29

30-3430-34

35-3935-39

40-4440-44

45-4945-49

50-5450-54

55-5955-59

60-6460-64

65-6965-69

70-7470-74

75+75+

13984

14620

16732

18000

16067

13680

12421

12868

13817

13573

11102

8803

7053

5575

4203

5997

13484

14112

16015

16906

15240

13462

12448

12883

13518

13162

10953

9032

7699

6391

5219

8211Males Females

100 10090 9080 8070 7060 6050 5040 4030 3020 2010 100 0

Population in Thousands

1993 2008Note: Population values shown for year 2008

Population Pyramid by AgeCHILE, VALDIVIA (1993-2008)

CSA - 25

Country's Summary Tables and Figures

CHILE1,2

(2003-2007, 1993-20083)

1 Country's incidence rates were estimated using aggregated data from the population-based cancer registries of

Antofagasta and Valdivia

2 National mortality data obtained from the WHO mortality database:

http://www.who.int/healthinfo/statistics/mortality_rawdata/en/index.html

3 Period for the analysis of trends: incidence rates were estimated using data from the population-based cancer

registry of Valdivia and National mortality data from the WHO mortality database

CSA - 26

CHILE* (2003-2007)Number of Cases in Major Diagnosis Groups

per Calendar Year

YEAR

SITE 2003n (%)

2004n (%)

2005n (%)

2006n (%)

2007n (%)

TOTALn (%)




*Aggregated data from the population-based cancer registries of Antofagasta and Valdivia

1

CSA - 27

CHILE* (2003-2007)Age Standardized Incidence Rate (World Population) per 100,000


YEAR

SITE 2003ASR (%)

2004ASR (%)

2005ASR (%)

2006ASR (%)

2007ASR (%)

TOTALASR (%)

MALESLip, oral cavity, and pharynx (C00-C14) 2.6 (1.0) 4.3 (1.6) 2.5 (1.0) 4.3 (1.5) 3.1 (1.2) 3.4 (1.3)Digestive organs (C15-C26) 68.7 (26.7) 73.9 (26.7) 60.6 (25.2) 72.9 (26.2) 63.7 (24.9) 67.9 (25.9)Respiratory organs (C30-C39) 36.3 (14.1) 40.8 (14.7) 38.4 (15.9) 42.0 (15.1) 38.6 (15.1) 39.2 (15.0)Bone, cartilage, and skin (C40-C44) 34.6 (13.5) 41.7 (15.1) 33.3 (13.8) 40.2 (14.5) 37.5 (14.6) 37.5 (14.3)Breast (C50) 0 (0.0) 0.5 (0.2) 0.2 (0.1) 0.2 (0.1) 0 (0.0) 0.2 (0.1)Male genitalia (C60-C63) 66.4 (25.8) 63.7 (23.0) 57.6 (23.9) 61.9 (22.3) 60.0 (23.4) 61.8 (23.6)Urinary organs (C64-C68) 23.6 (9.2) 24.7 (8.9) 18.6 (7.7) 26.0 (9.3) 20.8 (8.1) 22.7 (8.7)Eye, brain, and thyroid (C69-C75) 2.6 (1.0) 4.3 (1.6) 5.3 (2.2) 4.7 (1.7) 6.9 (2.7) 4.8 (1.8)Hematopoietic (C81-C96) 13.6 (5.3) 12.7 (4.6) 15.9 (6.6) 15.4 (5.5) 14.1 (5.5) 14.3 (5.5)Other and unspecified 9.2 (3.6) 10.3 (3.7) 8.5 (3.5) 10.2 (3.7) 11.3 (4.4) 9.9 (3.8)All sites 257.6 (100.0) 276.8 (100.0) 240.8 (100.0) 277.8 (100.0) 256.0 (100.0) 261.7 (100.0)



*Aggregated data from the population-based cancer registries of Antofagasta and Valdivia

1

CSA - 28

CHILE*

(200

3-20

07)

Incid

ence

per1

00,00

0byA

geGr

oup(yea

rs)

Males

SITE

ALL

CASE

SUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

R(W

)CU

M.RA

TE(0-74)†

MV (%)

DCO

(%)

Rank‡

ICD1

0

Lip,o

ralcavity,a

ndph

arynx(

C00-14

)72

00.5

..

..

..

0.51.6

5.18.0

6.321

.115

.720

.724

.83.1

3.40.4

088

115

C00-14

Oesoph

agus

(C15

)12

80

..

..

..

0.5.

0.52.5

4.87.4

12.6

47.1

67.3

103.2

5.56.1

0.71

7814

10C1

5Stom

ach(

C16)

623

0.

..

.1.0

0.62.2

4.914

.318

.433

.459

.998

.318

4.428

7.236

7.426

.629

.13.5

282

113

C16

Colon

(C18

)18

90

..

.0.5

0.50.6

0.51.6

2.28.9

12.7

22.1

30.9

35.3

82.8

113.5

8.18.7

0.99

8013

C18

Rectu

m(C19

-20)

116

0.

..

..

0.61.6

1.13.3

3.86.4

14.7

16.8

39.2

25.9

70.2

5.05.3

0.57

848

C19-20

Color

ectal

(C18

-20)

305

0.

..

0.50.5

1.12.2

2.75.5

12.7

19.1

36.8

47.7

74.5

108.7

183.7

13.0

14.0

1.56

8211

4C1

8-20

Anus

(C21

)9

0.

..

..

..

..

0.60.8

2.11.4

2.02.6

4.10.4

0.40.0

589

024

C21

Colon

,rectum

anda

nus(

C18-21

)31

40

..

.0.5

0.51.1

2.22.7

5.513

.319

.938

.949

.176

.5111.2

187.8

13.4

14.4

1.61

8211

C18-21

Liver

(C22

)98

01.1

.0.5

..

0.60.5

0.52.7

2.57.2

10.5

21.1

13.7

41.4

53.7

4.24.5

0.51

4030

13C2

2Ga

llblad

der(C2

3-24

)15

60

..

..

.0.6

.0.5

1.62.5

11.1

10.5

26.7

41.2

72.4

113.5

6.77.3

0.84

5123

9C2

3-24

Pancreas

(C25

)112

0.

..

..

..

.1.6

5.79.6

15.8

19.7

41.2

41.4

45.4

4.85.3

0.67

3229

12C2

5No

se,sinu

ses(

C30-31

)16

0.

..

..

.0.5

0.51.1

.0.8

3.25.6

2.02.6

4.10.7

0.70.0

881

1323

C30-31

Laryn

x(C3

2)57

0.

..

..

.0.5

0.50.5

3.24.0

6.39.8

13.7

28.5

26.8

2.42.6

0.34

829

18C3

2Lu

ng,tr

ache

aand

bron

chus

(C33

-34)

703

0.

..

..

0.61.1

0.57.7

17.7

46.2

101.9

169.9

227.5

297.5

309.6

30.0

33.8

4.35

5625

2C3

3-34

Melan

omao

fskin

(C43

)60

0.

..

0.9.

0.61.1

2.22.2

3.84.8

12.6

7.07.8

15.5

16.5

2.62.6

0.29

100

019

C43

Mesothe

lioma

(C45

)6

0.

..

..

.0.5

0.50.5

..

1.1.

..

4.10.3

0.20.0

110

00

25C4

5Ka

posisarco

ma(C46

)3

0.

..

..

..

0.5.

0.6.

..

2.0.

.0.1

0.10.0

210

00

27C4

6Brea

st(C50

)4

0.

..

..

..

.0.5

0.6.

..

2.0.

2.10.2

0.20.0

210

00

26C5

0Pe

nis(C60

)29

0.

..

..

..

0.5.

1.94.8

2.11.4

2.018

.116

.51.2

1.30.1

590

721

C60

Prostat

e(C6

1)10

910

..

..

..

.0.5

1.610

.119

.987

.215

0.234

7.260

0.292

2.646

.652

.16.0

989

81

C61

Testis(

C62)

219

01.1

.0.9

5.613

.124

.627

.018

.414

.84.4

4.04.2

4.22.0

.4.1

9.48.3

0.62

943

7C6

2Kidn

ey(C64

)21

80

1.1.

0.5.

..

0.52.2

2.210

.111.9

26.3

59.0

53.0

95.7

90.8

9.310

.41.3

171

106

C64

Blad

der(C6

7)23

70

..

..

..

1.11.6

6.613

.910

.429

.439

.341

.2113.8

132.1

10.1

10.8

1.29

8111

5C6

7Brain

,CNS

(C70

-72)

580

3.21.0

0.5.

0.51.1

0.51.1

3.32.5

3.26.3

5.615

.710

.314

.42.5

2.70.2

752

2117

C70-72

Thyro

id(C73

)34

0.

..

0.51.0

1.11.1

2.21.1

3.83.2

1.12.8

5.910

.32.1

1.51.4

0.17

973

20C7

3Ho

dgkin

disea

se(C81

)28

00.5

0.50.5

1.91.5

1.1.

1.62.2

0.61.6

2.1.

.2.6

6.21.2

1.10.0

810

00

22C8

1No

n-Ho

dgkin

lymph

oma(

C82-85

,C96

)10

00

2.6.

1.81.9

0.51.1

3.83.8

2.75.7

5.69.5

11.2

7.825

.937

.24.3

4.30.4

210

00

14C8

2-85

,C96

Multip

lemy

eloma

(C88

+C90

)68

0.

..

..

0.6.

1.1.

3.24.0

9.514

.025

.528

.524

.82.9

3.30.4

399

016

C88+

C90

Lymp

hoidleu

kaem

ia(C91

)36

04.8

3.00.9

2.80.5

0.6.

..

1.9.

.1.4

3.95.2

6.21.5

1.80.1

210

00

C91

Myelo

idleu

kaem

ia(C92

-94)

620

2.61.0

0.90.9

1.00.6

1.11.6

1.12.5

3.26.3

7.05.9

10.3

31.0

2.62.8

0.23

100

0C9

2-94

Leukae

miau

nspe

cified

(C95

)20

03.2

0.50.5

0.5.

0.6.

0.50.5

0.6.

2.11.4

.2.6

6.20.9

1.00.0

610

00

C95

Leukae

mia(

C91-95

)118

010

.64.5

2.34.2

1.51.7

1.12.2

1.65.1

3.28.4

9.89.8

18.1

43.3

5.05.6

0.42

100

011

C91-95

Othe

rand

unspecifie

d(O&

U)16

20

.0.5

0.5.

..

.1.1

3.36.3

11.1

20.0

21.1

49.0

54.3

99.1

6.97.5

0.84

4220

8O&

UAllsitesb

utC4

4(AL

LbC4

4)49

150

24.3

6.59.6

21.0

22.6

37.5

47.6

54.8

85.6

150.7

250.9

499.0

786.1

1265

.120

18.0

2724

.521

0.122

8.226

.4077

12AL

LbC4

4Allsites(

ALL)

5647

024

.36.5

9.621

.524

.638

.049

.762

.910

8.618

0.531

3.858

7.292

6.514

47.5

2250

.930

79.5

241.3

261.7

30.26

8011

ALL

*Agg

rega

tedda

tafro

mthe

popu

lation

-based

cancer

regis

trieso

fAnto

fagasta

andV

aldivia

UNK,

Unknow

n;AS

R(W

),Ag

eStan

dardize

dRate

(WorldPo

pulation

);CU

M.,C

umula

tive;

MV,M

icroscopic

Verification;

DCO,

Death

Certif

icate

Only

†Percent

‡Ran

kbased

onhig

hestAS

Rexclu

ding:

Allsitesb

utC4

4and

Allsites

1

CSA - 29

CHILE*

(200

3-20

07)

Incid

ence

per1

00,00

0byA

geGr

oup(yea

rs)

Female

s

SITE

ALL

CASE

SUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

R(W

)CU

M.RA

TE(0-74)†

MV (%)

DCO

(%)

Rank‡

ICD1

0

Lip,o

ralcavity,a

ndph

arynx(

C00-14

)41

00.5

.0.5

.1.1

0.60.6

.0.6

2.11.7

5.44.0

5.110

.418

.11.8

1.60.1

683

221

C00-14

Oesoph

agus

(C15

)87

0.

..

..

.0.6

0.60.6

1.40.9

4.35.4

18.7

31.3

65.4

3.93.1

0.32

7514

17C1

5Stom

ach(

C16)

262

0.

..

.0.6

0.60.6

3.75.0

12.6

13.1

21.6

40.4

56.2

71.0

132.1

11.8

10.3

1.13

7813

6C1

6Co

lon(C18

)23

70

..

0.51.5

0.61.8

1.82.4

8.74.2

7.819

.532

.359

.668

.9115.4

10.6

9.31.0

580

14C1

8Re

ctum

(C19

-20)

820

..

.0.5

.0.6

0.60.6

1.23.5

8.78.6

10.8

17.0

29.2

29.2

3.73.3

0.41

847

C19-20

Color

ectal

(C18

-20)

319

0.

.0.5

2.00.6

2.42.4

3.19.9

7.716

.528

.143

.176

.698

.114

4.614

.312

.71.4

581

124

C18-20

Anus

(C21

)21

0.

..

..

..

.0.6

2.13.5

3.21.3

1.74.2

8.30.9

0.80.0

881

523

C21

Colon

,rectum

anda

nus(

C18-21

)34

00

..

0.52.0

0.62.4

2.43.1

10.5

9.820

.031

.344

.478

.310

2.315

3.015

.313

.51.5

481

12C1

8-21

Liver

(C22

)82

01.1

..

..

.0.6

1.20.6

1.41.7

5.421

.515

.325

.141

.73.7

3.30.3

740

2416

C22

Gallblad

der(C2

3-24

)42

20

..

..

..

.1.8

9.314

.027

.937

.874

.0117.4

125.3

184.9

19.0

17.1

2.04

5515

2C2

3-24

Pancreas

(C25

)10

70

..

..

..

.1.2

2.52.8

2.613

.018

.823

.823

.059

.84.8

4.20.4

433

3114

C25

Nose,sinu

ses(

C30-31

)9

0.

..

..

..

.0.6

0.71.7

.1.3

..

5.60.4

0.30.0

278

1125

C30-31

Laryn

x(C3

2)17

0.

..

..

.0.6

..

1.41.7

2.24.0

1.78.4

2.80.8

0.70.1

082

624

C32

Lung

,trache

aand

bron

chus

(C33

-34)

298

0.

..

0.50.6

0.61.8

0.66.8

14.7

12.2

21.6

52.5

74.9

114.8

121.0

13.4

12.1

1.51

5521

5C3

3-34

Melan

omao

fskin

(C43

)52

0.

..

0.5.

.1.8

0.63.7

2.16.1

6.55.4

10.2

8.415

.32.3

2.10.2

398

019

C43

Mesothe

lioma

(C45

)8

0.

..

..

..

.0.6

.1.7

1.11.3

1.7.

2.80.4

0.30.0

310

00

26C4

5Ka

posisarco

ma(C46

)3

0.

..

.0.6

..

..

0.7.

.1.3

..

.0.1

0.10.0

110

00

27C4

6Brea

st(C50

)84

70

..

..

0.62.4

4.823

.349

.587

.590

.610

2.712

6.513

2.716

4.919

6.138

.035

.03.9

393

41

C50

Cervixu

teri(C

53)

347

0.

.0.5

.1.7

6.020

.925

.729

.730

.134

.032

.422

.932

.341

.855

.615

.613

.91.3

990

53

C53

Corpus

uteri(

C54)

900

..

..

..

1.82.4

5.04.2

9.613

.018

.820

.416

.716

.74.0

3.80.4

690

615

C54

Ovary(

C56)

136

0.

.0.5

.0.6

.3.0

3.77.4

11.2

13.1

17.3

20.2

35.7

20.9

25.0

6.15.7

0.67

809

10C5

6Kidn

ey(C64

)13

20

1.10.5

..

1.10.6

.1.8

1.94.9

10.4

20.5

25.6

32.3

29.2

41.7

5.95.6

0.65

7311

11C6

4Blad

der(C6

7)15

20

..

..

..

.0.6

4.32.8

5.217

.325

.634

.068

.964

.06.8

6.10.7

980

109

C67

Brain

,CNS

(C70

-72)

560

2.71.0

1.41.0

0.60.6

0.62.4

3.12.1

1.72.2

10.8

8.516

.75.6

2.52.5

0.28

4623

18C7

0-72

Thyro

id(C73

)19

80

..

.1.0

3.96.0

10.7

10.4

16.1

24.5

25.3

11.9

16.1

20.4

6.322

.28.9

8.20.7

698

17

C73

Hodg

kindis

ease

(C81

)27

0.

.1.0

1.01.7

0.60.6

1.2.

4.92.6

..

3.46.3

1.41.2

1.10.1

210

00

22C8

1No

n-Ho

dgkin

lymph

oma(

C82-85

,C96

)10

90

0.5.

..

0.61.8

0.62.4

5.07.0

7.88.6

12.1

22.1

10.4

51.4

4.94.3

0.40

100

013

C82-85

,C96

Multip

lemy

eloma

(C88

+C90

)50

0.

..

..

..

..

2.84.4

2.24.0

22.1

16.7

20.9

2.22.0

0.26

100

020

C88+

C90

Lymp

hoidleu

kaem

ia(C91

)46

04.4

2.11.0

1.50.6

1.80.6

0.60.6

2.82.6

1.14.0

5.12.1

9.72.1

2.10.1

510

00

C91

Myelo

idleu

kaem

ia(C92

-94)

460

0.5.

0.51.0

1.10.6

1.80.6

2.52.8

4.41.1

4.010

.24.2

13.9

2.11.9

0.18

100

0C9

2-94

Leukae

miau

nspe

cified

(C95

)14

0.

2.1.

..

.0.6

.0.6

.0.9

1.1.

.6.3

4.20.6

0.60.0

610

00

C95

Leukae

mia(

C91-95

)10

60

4.94.2

1.42.5

1.72.4

3.01.2

3.75.6

7.83.2

8.115

.312

.527

.84.8

4.60.3

910

00

12C9

1-95

Othe

rand

unspecifie

d(O&

U)18

20

0.5.

.1.0

.0.6

.0.6

1.92.8

12.2

11.9

29.6

37.4

54.3

104.3

8.27.1

0.76

4024

8O&

UAllsitesb

utC4

4(AL

LbC4

4)43

860

12.6

6.27.6

11.5

17.8

26.6

57.2

97.3

177.0

268.7

329.1

412.8

623.0

850.9

1020

.915

28.2

197.0

177.8

19.60

7810

ALLb

C44

Allsites(

ALL)

5153

012

.66.8

7.612

.018

.429

.064

.9111.4

211.7

315.6

380.5

493.9

730.7

976.8

1198

.418

45.2

231.5

208.1

22.85

819

ALL

*Agg

rega

tedda

tafro

mthe

popu

lation

-based

cancer

regis

trieso

fAnto

fagasta

andV

aldivia

UNK,

Unknow

n;AS

R(W

),Ag

eStan

dardize

dRate

(WorldPo

pulation

);CU

M.,C

umula

tive;

MV,M

icroscopic

Verification;

DCO,

Death

Certif

icate

Only

†Percent

‡Ran

kbased

onhig

hestAS

Rexclu

ding:

Allsitesb

utC4

4and

Allsites

1

CSA - 30

CHILE (2003-2007)Number of Deaths in Major Diagnosis Groups

per Calendar Year

YEAR

SITE 2003n (%)

2004n (%)

2005n (%)

2006n (%)

2007n (%)

TOTALn (%)

MALESLip, oral cavity, and pharynx (C00-C14) 134 (1.3) 130 (1.3) 144 (1.4) 123 (1.1) 147 (1.4) 678 (1.3)Digestive organs (C15-C26) 4509 (44.4) 4383 (42.7) 4555 (43.0) 4644 (43.1) 4483 (42.0) 22574 (43.0)Respiratory organs (C30-C39) 1415 (13.9) 1569 (15.3) 1592 (15.0) 1649 (15.3) 1654 (15.5) 7879 (15.0)Bone, cartilage, and skin (C40-C44) 97 (1.0) 84 (0.8) 92 (0.9) 80 (0.7) 66 (0.6) 419 (0.8)Male genitalia (C60-C63) 1581 (15.6) 1561 (15.2) 1607 (15.2) 1679 (15.6) 1672 (15.7) 8100 (15.4)Urinary organs (C64-C68) 490 (4.8) 531 (5.2) 607 (5.7) 541 (5.0) 574 (5.4) 2743 (5.2)Eye, brain, and thyroid (C69-C75) 171 (1.7) 202 (2.0) 189 (1.8) 173 (1.6) 221 (2.1) 956 (1.8)Hematopoietic (C81-C96) 800 (7.9) 804 (7.8) 801 (7.6) 852 (7.9) 841 (7.9) 4098 (7.8)Other and unspecified 953 (9.4) 999 (9.7) 998 (9.4) 1032 (9.6) 1016 (9.5) 4998 (9.5)All sites 10150 (100.0) 10263 (100.0) 10585 (100.0) 10773 (100.0) 10674 (100.0) 52445 (100.0)



1

CSA - 31

CHILE (2003-2007)Age Standardized Mortality Rate (World Population) per 100,000


YEAR

SITE 2003ASMR (%)

2004ASMR (%)

2005ASMR (%)

2006ASMR (%)

2007ASMR (%)

TOTALASMR (%)

MALESLip, oral cavity, and pharynx (C00-C14) 1.8 (1.3) 1.7 (1.3) 1.8 (1.4) 1.5 (1.2) 1.7 (1.4) 1.7 (1.3)Digestive organs (C15-C26) 58.5 (44.9) 54.8 (43.1) 54.8 (43.5) 53.8 (43.5) 49.9 (42.4) 54.2 (43.5)Respiratory organs (C30-C39) 18.7 (14.4) 20.1 (15.8) 19.6 (15.6) 19.4 (15.7) 18.8 (16.0) 19.3 (15.5)Bone, cartilage, and skin (C40-C44) 1.2 (1.0) 1.0 (0.8) 1.0 (0.8) 0.9 (0.7) 0.7 (0.6) 1.0 (0.8)Male genitalia (C60-C63) 19.1 (14.7) 18.0 (14.2) 17.9 (14.2) 17.9 (14.5) 17.0 (14.4) 18.0 (14.4)Urinary organs (C64-C68) 6.4 (4.9) 6.7 (5.3) 7.1 (5.7) 6.3 (5.1) 6.2 (5.3) 6.5 (5.2)Eye, brain, and thyroid (C69-C75) 2.2 (1.7) 2.5 (2.0) 2.3 (1.8) 2.1 (1.7) 2.6 (2.2) 2.4 (1.9)Hematopoietic (C81-C96) 10.3 (7.9) 10.1 (8.0) 9.7 (7.7) 9.9 (8.0) 9.5 (8.0) 9.9 (7.9)Other and unspecified 12.1 (9.3) 12.1 (9.5) 11.7 (9.3) 11.7 (9.5) 11.3 (9.6) 11.8 (9.5)All sites 130.3 (100.0) 127.0 (100.0) 126.0 (100.0) 123.6 (100.0) 117.9 (100.0) 124.8 (100.0)



1

CSA - 32

CHILE(200

3-20

07)

Morta

lityp

er10

0,000

byAg

eGroup

(yea

rs)

Males

SITE

ALL

DEAT

HSUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

MR (W)

CUM.

RATE

(0-74)†

Rank‡

ICD1

0

Lip,o

ralcavity,&

pharynx(

C00-14

)67

80

..

.0.1

0.00.1

0.10.1

0.51.4

2.25.0

7.610

.415

.215

.81.7

1.70.2

15C0

0-14

Oesoph

agus

(C15

)22

000

..

.0.1

0.0.

0.10.2

0.41.4

3.66.5

17.3

33.1

54.1

95.7

5.55.2

0.67

C15

Stom

ach(

C16)

1021

50

..

.0.0

0.10.5

1.52.9

7.512

.527

.951

.487

.514

8.123

4.635

0.325

.324

.62.9

1C1

6Co

lon(C18

)22

790

..

.0.1

0.20.2

0.50.8

1.31.9

4.88.2

15.9

29.1

47.0

100.4

5.75.3

0.6C1

8Re

ctum

(C19

-C20

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

C19-C2

0Co

lorectal

(C18

-20)

00

..

..

..

..

..

..

..

..

0.00.0

0.024

C18-20

Anus

(C21

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

24C2

1Co

lon,rectum

anda

nus(

C18-21

)34

250

..

.0.1

0.30.4

1.01.7

2.03.6

7.012

.924

.746

.272

.914

0.78.5

8.10.9

C18-21

Liver

(C22

)22

270

0.30.1

0.00.1

0.10.1

0.20.3

0.92.3

4.511.4

21.1

34.1

53.2

76.7

5.55.4

0.66

C22

Gallblad

der(C2

3-24

)24

980

..

.0.0

.0.1

0.10.5

1.93.3

7.110

.822

.834

.151

.593

.46.2

6.00.7

5C2

3-24

Pancreas

(C25

)20

090

.0.0

..

.0.0

0.20.8

1.52.7

6.713

.617

.830

.143

.460

.05.0

4.90.6

8C2

5No

se,sinu

ses(

C30-31

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

24C3

0-31

Laryn

x(C3

2)55

50

..

.0.0

..

0.00.1

0.10.4

1.53.0

5.47.9

14.8

18.7

1.41.4

0.216

C32

Lung

(C33

-34)

7324

0.

.0.0

0.20.1

0.40.8

1.13.0

8.219

.842

.476

.0117.1

170.4

225.0

18.2

18.0

2.22

C33-34

Melan

omao

fskin

(C43

)41

90

..

.0.0

0.00.3

0.20.5

1.11.1

1.82.3

3.84.6

5.111.0

1.01.0

0.118

C43

Mesothe

lioma

(C45

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

24C4

5Ka

posisarco

ma(C46

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

24C4

6Brea

st(C50

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

24C5

0Pe

nis(C60

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

24C6

0Prostat

e(C6

1)76

300

..

..

0.00.0

.0.0

0.20.5

3.67.2

25.6

69.5

159.4

505.0

18.9

16.9

1.33

C61

Testis(

C62)

470

0.

..

0.61.6

2.82.7

2.21.5

1.00.5

0.91.0

0.71.3

3.01.2

1.10.1

17C6

2Kidn

ey(C64

)16

230

0.10.1

0.10.1

.0.1

0.10.4

1.12.9

5.69.5

14.1

25.4

34.6

48.2

4.04.0

0.59

C64

Blad

der(C6

7)1120

0.

..

..

.0.1

0.20.5

1.12.2

3.97.0

12.4

23.0

54.8

2.82.6

0.312

C67

Brain

,CNS

(C70

-72)

809

00.5

0.70.9

0.60.3

0.41.0

0.71.8

2.33.2

5.06.0

10.0

11.0

9.92.0

2.00.2

14C7

0-72

Thyro

id(C73

)14

70

..

..

..

0.0.

0.00.3

0.50.9

1.22.7

3.04.3

0.40.4

0.019

C73

Hodg

kindis

ease

(C81

)12

60

.0.1

0.00.1

0.20.4

0.20.4

0.10.1

0.20.5

1.21.3

1.81.9

0.30.3

0.020

C81

Non-Ho

dgkin

lymph

oma(

C82-85

,C96

)14

210

0.20.1

0.30.6

0.81.2

1.31.5

2.62.7

4.57.3

10.0

16.9

22.8

37.3

3.53.4

0.411

C82-85

,C96

Multip

lemy

eloma

(C88

+C90

)98

80

.0.0

..

.0.0

0.10.2

0.61.2

3.56.8

10.1

14.0

20.9

29.5

2.52.4

0.313

C88+

C90

Lymp

hoidleu

kaem

ia(C91

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

C91

Myelo

idleu

kaem

ia(C92

-94)

00

..

..

..

..

..

..

..

..

0.00.0

0.0C9

2-94

Leukae

miau

nspe

cified

(C95

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

C95

Leukae

mia(

C91-95

)15

630

1.51.5

1.32.0

1.71.8

2.01.8

1.92.4

3.75.8

9.413

.421

.838

.03.9

3.80.4

10C9

1-95

Othe

rand

unspecifie

d(O&

U)49

980

0.70.7

0.61.6

1.51.9

3.13.6

4.77.0

12.1

23.1

36.3

56.4

89.4

180.0

12.4

11.8

1.24

O&U

Allsites(

ALL)

5244

50

3.33.4

3.16.2

6.710

.514

.719

.033

.858

.512

1.523

0.240

6.168

8.21104

.319

99.0

130.1

124.8

13.5

ALL

UNK,

Unknow

n;AS

MR(W

),Ag

eStan

dardize

dMortality

Rate

(WorldPo

pulation

);CU

M.,C

umula

tive

†Percent

‡Ran

kbased

onhig

hestAS

MRexclu

ding:

Allsites

1

CSA - 33

CHILE(200

3-20

07)

Morta

lityp

er10

0,000

byAg

eGroup

(yea

rs)

Female

s

SITE

ALL

DEAT

HSUN

KAG

E0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

CRUD

ERA

TEAS

MR (W)

CUM.

RATE

(0-74)†

Rank‡

ICD1

0

Lip,o

ralcavity,&

pharynx(

C00-14

)29

10

..

.0.0

0.00.1

0.20.2

0.20.6

0.60.9

1.12.6

3.08.8

0.70.5

0.020

C00-14

Oesoph

agus

(C15

)14

180

..

..

..

0.10.1

0.30.7

1.23.2

5.411.3

22.6

51.7

3.42.3

0.212

C15

Stom

ach(

C16)

5095

0.

.0.0

.0.2

0.71.3

1.93.6

5.88.8

16.4

26.2

44.4

76.2

151.8

12.4

8.90.9

4C1

6Co

lon(C18

)29

120

..

..

0.10.3

0.70.8

1.63.0

4.78.6

16.2

23.3

36.8

94.9

7.15.0

0.5C1

8Re

ctum

(C19

-C20

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

C19-C2

0Co

lorectal

(C18

-20)

00

..

..

..

..

..

..

..

..

0.00.0

0.025

C18-20

Anus

(C21

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

25C2

1Co

lon,rectum

anda

nus(

C18-21

)39

870

..

.0.1

0.20.4

0.91.3

2.44.8

7.812

.722

.433

.849

.112

3.79.7

6.90.7

C18-21

Liver

(C22

)18

650

0.10.1

0.10.0

0.00.1

0.20.4

0.82.1

4.27.3

11.7

20.4

28.1

49.8

4.53.4

0.49

C22

Gallblad

der(C2

3-24

)66

580

..

..

0.00.1

0.31.8

5.512

.124

.636

.955

.675

.192

.513

4.316

.212

.91.5

1C2

3-24

Pancreas

(C25

)25

240

..

..

0.10.2

0.20.4

1.12.9

6.110

.318

.627

.739

.064

.16.1

4.70.5

7C2

5No

se,sinu

ses(

C30-31

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

25C3

0-31

Laryn

x(C3

2)86

0.

..

..

..

.0.1

0.10.4

0.20.7

0.91.5

2.00.2

0.20.0

22C3

2Lu

ng(C33

-34)

4060

00.0

.0.0

.0.1

0.30.3

0.81.5

4.99.5

18.6

30.8

48.8

65.7

95.6

9.97.6

0.95

C33-34

Melan

omao

fskin

(C43

)35

00

0.0.

.0.0

0.00.2

0.20.2

0.60.7

1.01.7

2.32.6

3.78.2

0.80.7

0.118

C43

Mesothe

lioma

(C45

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

25C4

5Ka

posisarco

ma(C46

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

25C4

6Brea

st(C50

)56

030

..

..

0.10.6

1.95.6

10.3

17.3

25.9

32.5

38.3

46.4

56.2

102.7

13.6

10.9

1.22

C50

Cervixu

teri (C

53)

3728

0.

..

0.00.3

1.23.9

6.38.7

11.5

16.8

20.1

22.2

30.7

35.6

59.6

9.17.3

0.86

C53

Corpus

uteri (

C54)

637

0.

..

..

.0.1

0.10.3

0.51.4

2.95.3

8.211.8

14.0

1.51.2

0.216

C54

Ovary(

C56)

1730

00.0

..

0.10.2

0.50.5

1.42.5

6.27.9

12.1

12.9

19.3

17.9

24.2

4.23.5

0.48

C56

Kidn

ey(C64

)90

70

0.20.0

.0.1

0.00.0

0.00.3

0.61.4

1.94.1

6.48.6

14.1

22.5

2.21.7

0.214

C64

Blad

der(C6

7)67

00

..

..

0.0.

0.00.1

0.10.4

0.51.7

3.65.3

9.523

.91.6

1.10.1

17C6

7Brain

,CNS

(C70

-72)

662

00.6

0.60.4

0.50.4

0.50.7

0.71.5

0.92.5

3.04.6

7.26.0

7.71.6

1.40.2

15C7

0-72

Thyro

id(C73

)31

20

..

..

0.0.

.0.0

0.30.3

0.60.9

1.83.5

4.49.2

0.80.6

0.119

C73

Hodg

kindis

ease

(C81

)12

00

..

0.10.1

0.30.2

0.10.2

0.30.3

0.10.4

0.50.8

1.02.2

0.30.2

0.021

C81

Non-Ho

dgkin

lymph

oma(

C82-85

,C96

)12

820

0.10.1

0.10.1

0.60.7

0.70.7

1.42.1

3.15.3

9.011.7

17.0

29.1

3.12.4

0.311

C82-85

,C96

Multip

lemy

eloma

(C88

+C90

)91

00

.0.0

..

.0.0

0.10.0

0.30.5

1.74.4

6.611.9

16.4

21.7

2.21.7

0.213

C88+

C90

Lymp

hoidleu

kaem

ia(C91

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

C91

Myelo

idleu

kaem

ia(C92

-94)

00

..

..

..

..

..

..

..

..

0.00.0

0.0C9

2-94

Leukae

miau

nspe

cified

(C95

)0

0.

..

..

..

..

..

..

..

.0.0

0.00.0

C95

Leukae

mia(

C91-95

)14

380

1.41.1

1.21.4

1.31.3

1.61.6

2.23.0

3.65.8

6.19.8

11.4

26.0

3.52.9

0.310

C91-95

Othe

rand

unspecifie

d(O&

U)54

450

0.40.4

0.41.1

1.21.1

1.82.9

4.78.2

12.2

19.2

30.9

45.0

67.5

149.6

13.2

9.81.0

3O&

UAllsites(

ALL)

4929

00

2.92.3

2.23.6

5.18.1

14.9

27.0

48.5

86.2

140.6

218.2

319.3

471.9

644.8

1171

.5119.7

91.8

10.0

ALL

UNK,

Unknow

n;AS

MR(W

),Ag

eStan

dardize

dMortality

Rate

(WorldPo

pulation

);CU

M.,C

umula

tive

†Percent

‡Ran

kbased

onhig

hestAS

MRexclu

ding:

Allsites

1

CSA - 34

110

100

1993 1998 2003 2008

Oesophagus (C15)

110

100

1993 1998 2003 2008

Stomach (C16)

110

100

1993 1998 2003 2008


110

.1

1993 1998 2003 2008

Liver (C22)

110

100

1993 1998 2003 2008


110

1993 1998 2003 2008

Pancreas (C25)

.11

10

1993 1998 2003 2008

Larynx (C32)

110

100

1993 1998 2003 2008

Lung (C33−34)

.11

10

1993 1998 2003 2008


1010

0

1993 1998 2003 2008

Breast (C50)

110

100

1993 1998 2003 2008

Cervix uteri (C53)

.11

10

1993 1998 2003 2008

Corpus uteri (C54)

Age

sta

ndar

dize

d ra

tes

(log

scal

e) p

er 1

00,0

00 p

erso

n−ye

ars

Calendar Year


*Incidence rates were estimated using data from the population−based cancer registry of Valdivia

Trends in cancer incidence* and mortality by sex, all ages

CHILE (1993−2008)

Incidence, Males Mortality, Males

Incidence, Females Mortality, FemalesCSA - 35

110

100

1993 1998 2003 2008

Ovary (C56)

.11

10

1993 1998 2003 2008

Penis (C60)

1010

0

1993 1998 2003 2008

Prostate (C61)

.11

1010

0

1993 1998 2003 2008

Testis (C62)

110

100

1993 1998 2003 2008

Kidney (C64)

.11

10

1993 1998 2003 2008

Bladder (C67)

110

1993 1998 2003 2008

Brain, CNS (C70-72)

.11

10

1993 1998 2003 2008

Thyroid (C73)

.11

10

1993 1998 2003 2008


110

1993 1998 2003 2008

Non-Hodgkin (C82-85,C96)

110

100

1993 1998 2003 2008

Leukaemia (C91-95)

1010

010

00

1993 1998 2003 2008

All sites but C44

Age

sta

ndar

dize

d ra

tes

(log

scal

e) p

er 1

00,0

00 p

erso

n-ye

ars

Calendar Year


*Incidence rates were estimated using data from the population-based cancer registry of Valdivia

Trends in cancer incidence* and mortality by sex, all ages

CHILE (1993-2008)

Incidence, Males Mortality, Males

Incidence, Females Mortality, Females

CSA - 36

*-3.3*-4.2

-3.8-4.1

-3.8-3.0

-0.3-2.9

-2.5-2.2

-1.4-2.0

-0.8-1.8

0.4-1.4

-0.9-1.4

-7.60.4

0.11.5

-0.92.9

-0.8*3.2

1.8*3.9

-2.9*4.5

2.05.1

-0.8*7.3

-2.1*10.2


Stomach (C16)

Larynx (C32)

Oesophagus (C15)



Lung (C33-34)

Liver (C22)

Bladder (C67)

Thyroid (C73)


Pancreas (C25)

Leukaemia (C91-95)

Prostate (C61)


Testis (C62)

Brain, CNS (C70-72)

Kidney (C64)



Note: Incidence rates were estimated using data from the population-based cancer registry of Valdivia

Estimated Annual Percent Change in Incidence and Mortality Ratesby Cancer Site in Males, all ages

CHILE (1997-2008)

Incidence Mortality

CSA - 37

-4.5*-6.2

-3.8-5.8

-1.1-4.3

-3.4-3.4

1.8-2.6

-3.2-2.1

1.4-1.4

-0.3-0.9

1.6-0.8

0.4-0.8

-0.6-0.5

3.3-0.3

-2.11.6

0.51.9

-1.02.5

-0.02.8

-0.13.8

-1.06.2

-2.010.7


Cervix uteri (C53)

Oesophagus (C15)

Ovary (C56)

Stomach (C16)

Bladder (C67)


Lung (C33-34)

Liver (C22)

Pancreas (C25)

Corpus uteri (C54)


Brain, CNS (C70-72)



Breast (C50)

Leukaemia (C91-95)

Kidney (C64)

Thyroid (C73)



Note: Incidence rates were estimated using data from the population-based cancer registry of Valdivia

Estimated Annual Percent Change in Incidence and Mortality Ratesby Cancer Site in Females, all ages

CHILE (1997-2008)

Incidence Mortality

CSA - 38

0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

0-4

5-9

10-14

15-19

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75+

18936

20013

21877

21401

19916

17882

18504

18430

18232

15790

12557

9520

7124

5099

3865

4845

18253

19253

21033

19968

17979

16541

16783

16336

16154

14290

11485

9254

7432

5876

4790

7192Males Females

100 10090 9080 8070 7060 6050 5040 4030 3020 2010 100 0

Population in Thousands*Aggregated population from Antofagasta and Valdivia

Average annual person-yearsCHILE* (2003-2007)

CSA - 39

Documents

CHILE - International Agency for Research on Cancer · CHILE . This country profile for the Cancer in Central and South America project provides, for each participating cancer registry